ALL
Pharma in China
Pharma Experts
Market News
Products Guide
Brand Story
-
GSK’s COVID-19 antibody shows potential in older patients
March 01, 2021GlaxoSmithKline (GSK) has reported Phase II results for its investigational monoclonal antibody otilimab in hospitalised COVID-19 patients – and the data is mixed. -
First UK patient given GSK’s experimental arthritis drug in COVID-19 trial
September 30, 2020A patient in Manchester is the first in the UK to be treated in a new COVID-19 trial investigating the use of an experimental arthritis drug, otilimab, for severe lung disease related to the novel coronavirus. -
Phase III programme for the use otilimab for rheumatoid arthritis launched
July 08, 2019A Phase III clinical development programme testing otilimab in patients with RA has begun.
Pharma Sources Insight January 2025
